Healthcare -
Biotechnology - NYSE - DK
$ 85.25
-0.105 %
$ 372 B
Market Cap
28.8
P/E
NVO - ACCOUNTS PAYABLE
Accounts Payable NVO - Novo Nordisk A/S
25.6 B
LAST VALUE
69.91%
2 YEAR CAGR
30.54%
5 YEAR CAGR
20.13%
10 YEAR CAGR